Cure diseases through next generation 4D tissue bioprinting

published: 23 Mar 2022  |  
547visits
No s'ha trobat cap mèdia.
Sinopsi
Idiomes
Share
Download
Comments (0)
  • Creatio, the Center for the Production and Validation of Advanced Therapies at the University of Barcelona (UB), ​​has obtained funding of almost one million euros from the Spanish Ministry of Science and Innovation to acquire and set up one of the first GMP-qualified 4D bio-printers in the world.

    The director of Creatio, Dr. Josep M. Canals, and the University’s Dean, Dr. Joan Guàrdia, explain the importance of this acquisition for the development of innovative cell treatments for incurable diseases such as neurodegenerative disorders. With this acquisition, Creatio places itself at the forefront of translational research in tissue engineering.

    Llicència Creative Commons by-nc-nd
    Notify
    Wrong content alertTancar
    Si heu detectat algún error a aquest vídeo ens ho podeu notificar al correu mencionant l'identificador del vídeo: 117254
    ©Universitat de Barcelona
  • Subtítols  Sense subtítols  English  
  • Codi per incrustar aquest vídeo
  • To download files "Right click" on the link and "Save link as".
    Subtítols: English (.srt)
Pàgina